Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, tividenofusp alfa (DNL310), for the treatment of individuals with Hunter ...
(RTTNews) - Denali Therapeutics Inc. (DNLI), Wednesday announced that the company's initiation of a rolling submission of a biologics license application (BLA) for accelerated approval of tividenofusp ...
Researchers have given the gene therapy made at UManchester to two out of five planned patients in a Phase I/II trial, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback